LINKPH

Link Pharma Chem financials

Market cap
₹13 Cr

Quarterly results

Q1 FY27: revenue up 12.3%, net profit down 20.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue5 5 6 8 6 +31%7 +26%7 +2%9 +12%
EBITDA-0 0 -0 1 0 +213%1 +527%-0 −4%0 −30%
Net profit-0 -1 -0 0 0 +106%0 +110%-0 −17%0 −20%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −19.9% 1Y

₹25.0₹30.0₹35.0Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹34.27 on 9 Sept 2025 → ₹27.44. High ₹37.99 (17 Sept 2025), low ₹21.86 (17 Mar 2026).

Financials, as filed

Revenue fell 4.2% a year over 2 years, FY24 to FY26. Operating margin widened to 5.2%.

Year endingFY24FY25FY26
Revenue₹30 Cr₹25 Cr₹27 Cr
Operating profit₹-1 Cr₹0 Cr₹1 Cr
Operating margin-2.2%0.5%5.2%
Interest₹1 Cr₹1 Cr₹1 Cr
Depreciation₹1 Cr₹1 Cr₹1 Cr
Net profit₹-1 Cr₹-1 Cr₹0 Cr
Net margin-4.5%-4.0%0.3%
Cash from operations₹-0 Cr₹3 Cr₹2 Cr
Free cash flow₹-1 Cr₹2 Cr₹0 Cr
ROCE-4.8%-3.0%3.5%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
Reserves₹8 Cr₹10 Cr₹11 Cr₹9 Cr₹9 Cr₹8 Cr
Borrowings₹4 Cr₹6 Cr₹9 Cr₹9 Cr₹8 Cr₹7 Cr
Other liabilities₹10 Cr₹8 Cr₹9 Cr₹3 Cr₹4 Cr₹5 Cr
Total liabilities₹26 Cr₹29 Cr₹32 Cr₹26 Cr₹26 Cr₹25 Cr
Fixed assets₹9 Cr₹9 Cr₹9 Cr₹10 Cr₹10 Cr₹10 Cr
Capital work in progress₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investments₹0 Cr₹5 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr
Other assets₹17 Cr₹15 Cr₹20 Cr₹13 Cr₹13 Cr₹12 Cr
Total assets₹26 Cr₹29 Cr₹32 Cr₹26 Cr₹26 Cr₹25 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, the public trimmed −0.92 pp while promoters added +0.91 pp. The shareholder count shrank 2% to 6,005.

Promoters
52.4%
DIIs
0.0%
Public
47.6%

Since Jun 2025

  • Public −0.92 pp
  • Promoters +0.91 pp
  • DIIs 0.00 pp

How it drifted, 12 quarters

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Dec '23: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Mar '24: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Jun '24: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Sep '24: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Dec '24: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Mar '25: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Jun '25: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Sep '25: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Dec '25: Promoters 51.5%, DIIs 0.0%, Public 48.5%.Mar '26: Promoters 52.4%, DIIs 0.0%, Public 47.6%.Jun '26: Promoters 52.4%, DIIs 0.0%, Public 47.6%.

Who was buying across the market this quarter →

Who is on the register

Named in the Jun 2026 filing

Every holder of Link Pharma Chem Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Rishikesh Satishbhai Thakur 21.95%unchanged
Maya Satish Thakur 15.55%unchanged
Satish Ganpatrao Thakur 14.91%unchanged
Gurudev Marketing Pvt. Ltd. 5.76%unchanged
Daksha Vishanji Kotak 1.87%unchanged
Chirayu Jayesh Shah (Huf) 1.20%unchanged
Thakorbhai Vinubhai Mistry 1.18%unchanged
Mangala Shriniwas Thakur 0.00%unchanged
Soniya Rajesh Wani 0.00%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Learn to analyse Link Pharma Chem Ltd.

Guides on how to read this kind of business and the numbers that matter.